Disseminated intravascular coagulation

Healthy pregnancy is accompanied by changes in the haemostatic system which convert it into a hypercoagulable state vulnerable to a spectrum of disorders ranging from venous thromboembolism to disseminated intravascular coagulation (DIC). This latter is always a secondary phenomenon triggered by spe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Best practice & research. Clinical obstetrics & gynaecology 2001-08, Vol.15 (4), p.623-644
1. Verfasser: Letsky, Elizabeth A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 644
container_issue 4
container_start_page 623
container_title Best practice & research. Clinical obstetrics & gynaecology
container_volume 15
creator Letsky, Elizabeth A.
description Healthy pregnancy is accompanied by changes in the haemostatic system which convert it into a hypercoagulable state vulnerable to a spectrum of disorders ranging from venous thromboembolism to disseminated intravascular coagulation (DIC). This latter is always a secondary phenomenon triggered by specific disorders such as abruptio placentae and amniotic fluid embolism due to release of thromboplastin intravascularly or endothelial damage resulting from pre-eclampsia and sepsis. In modern obstetric practice the most common cause is haemorrhagic shock with delay in resuscitation leading to endothelial damage. The initial management of massive obstetric haemorrhage is the same whether associated with coagulopathy initially or not. Low-grade DIC, associated with pre-eclampsia, is monitored haematologically by serial platelet counts and serum fibrin degradation products (FDPs). Supportive measures and removal of the triggering mechanism are the key to successful management. Outcome depends primarily on our ability to deal with the trigger and not on direct attempts to correct the coagulation deficit.
doi_str_mv 10.1053/beog.2001.0204
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71044252</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1521693401902044</els_id><sourcerecordid>71044252</sourcerecordid><originalsourceid>FETCH-LOGICAL-c340t-94e16bf007deece3b6399d2c5afa33acf78da19f8088d6d11942e412c20994423</originalsourceid><addsrcrecordid>eNp1kDtPwzAUhS0EoqWwMqJO3RLutZ00HlF5SpVYYLYc-6YyyqPYSSX-PYlaiYnpnuE7R7ofY7cIKUIm7kvqdikHwBQ4yDM2x0zwBJXg51PmmORKyBm7ivELQAjFs0s2Q5TrokA1Z6tHHyM1vjU9uaVv-2AOJtqhNmFpO7MbQ--79ppdVKaOdHO6C_b5_PSxeU227y9vm4dtYoWEPlGSMC8rgLUjsiTKXCjluM1MZYQwtloXzqCqCigKlztEJTlJ5JaDUlJysWCr4-4-dN8DxV43Plqqa9NSN0S9RhixbALTI2hDF2OgSu-Db0z40Qh6MqMnM3oyoyczY-HutDyUDbk__KRiBIojQON_B09BR-upteR8INtr1_n_tn8BGdxxWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71044252</pqid></control><display><type>article</type><title>Disseminated intravascular coagulation</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Letsky, Elizabeth A.</creator><creatorcontrib>Letsky, Elizabeth A.</creatorcontrib><description>Healthy pregnancy is accompanied by changes in the haemostatic system which convert it into a hypercoagulable state vulnerable to a spectrum of disorders ranging from venous thromboembolism to disseminated intravascular coagulation (DIC). This latter is always a secondary phenomenon triggered by specific disorders such as abruptio placentae and amniotic fluid embolism due to release of thromboplastin intravascularly or endothelial damage resulting from pre-eclampsia and sepsis. In modern obstetric practice the most common cause is haemorrhagic shock with delay in resuscitation leading to endothelial damage. The initial management of massive obstetric haemorrhage is the same whether associated with coagulopathy initially or not. Low-grade DIC, associated with pre-eclampsia, is monitored haematologically by serial platelet counts and serum fibrin degradation products (FDPs). Supportive measures and removal of the triggering mechanism are the key to successful management. Outcome depends primarily on our ability to deal with the trigger and not on direct attempts to correct the coagulation deficit.</description><identifier>ISSN: 1521-6934</identifier><identifier>EISSN: 1532-1932</identifier><identifier>DOI: 10.1053/beog.2001.0204</identifier><identifier>PMID: 11478819</identifier><language>eng</language><publisher>Netherlands: Elsevier Ltd</publisher><subject>Abortion, Therapeutic - adverse effects ; abruptio placentae ; Abruptio Placentae - complications ; Abruptio Placentae - physiopathology ; Abruptio Placentae - therapy ; amniotic fluid embolism ; Blood Transfusion ; coagulopathy ; Disseminated Intravascular Coagulation - etiology ; Disseminated Intravascular Coagulation - physiopathology ; Disseminated Intravascular Coagulation - therapy ; Embolism, Amniotic Fluid - complications ; Embolism, Amniotic Fluid - physiopathology ; Embolism, Amniotic Fluid - therapy ; Embolization, Therapeutic ; Fatty Liver - complications ; Fatty Liver - physiopathology ; Fatty Liver - therapy ; Female ; Fetal Death - complications ; Fetal Death - physiopathology ; Fetal Death - therapy ; fibrinolysis ; haemostatis ; Hemolytic-Uremic Syndrome - complications ; Hemolytic-Uremic Syndrome - physiopathology ; Hemolytic-Uremic Syndrome - therapy ; Humans ; low-grade DIC ; massive haemorrhage ; Placenta Accreta - complications ; Placenta Accreta - physiopathology ; Placenta Accreta - therapy ; Plasma ; Plasma Substitutes - therapeutic use ; pre-eclampsia ; Pre-Eclampsia - complications ; Pre-Eclampsia - physiopathology ; Pre-Eclampsia - therapy ; Pregnancy ; Pregnancy Complications, Cardiovascular - etiology ; Pregnancy Complications, Cardiovascular - physiopathology ; Pregnancy Complications, Cardiovascular - therapy ; Purpura, Schoenlein-Henoch - complications ; Purpura, Schoenlein-Henoch - physiopathology ; Purpura, Schoenlein-Henoch - therapy ; sepsis ; transfusion</subject><ispartof>Best practice &amp; research. Clinical obstetrics &amp; gynaecology, 2001-08, Vol.15 (4), p.623-644</ispartof><rights>2001 Harcourt Publishers Ltd</rights><rights>Copyright 2001 Harcourt Publishers Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c340t-94e16bf007deece3b6399d2c5afa33acf78da19f8088d6d11942e412c20994423</citedby><cites>FETCH-LOGICAL-c340t-94e16bf007deece3b6399d2c5afa33acf78da19f8088d6d11942e412c20994423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1053/beog.2001.0204$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11478819$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Letsky, Elizabeth A.</creatorcontrib><title>Disseminated intravascular coagulation</title><title>Best practice &amp; research. Clinical obstetrics &amp; gynaecology</title><addtitle>Best Pract Res Clin Obstet Gynaecol</addtitle><description>Healthy pregnancy is accompanied by changes in the haemostatic system which convert it into a hypercoagulable state vulnerable to a spectrum of disorders ranging from venous thromboembolism to disseminated intravascular coagulation (DIC). This latter is always a secondary phenomenon triggered by specific disorders such as abruptio placentae and amniotic fluid embolism due to release of thromboplastin intravascularly or endothelial damage resulting from pre-eclampsia and sepsis. In modern obstetric practice the most common cause is haemorrhagic shock with delay in resuscitation leading to endothelial damage. The initial management of massive obstetric haemorrhage is the same whether associated with coagulopathy initially or not. Low-grade DIC, associated with pre-eclampsia, is monitored haematologically by serial platelet counts and serum fibrin degradation products (FDPs). Supportive measures and removal of the triggering mechanism are the key to successful management. Outcome depends primarily on our ability to deal with the trigger and not on direct attempts to correct the coagulation deficit.</description><subject>Abortion, Therapeutic - adverse effects</subject><subject>abruptio placentae</subject><subject>Abruptio Placentae - complications</subject><subject>Abruptio Placentae - physiopathology</subject><subject>Abruptio Placentae - therapy</subject><subject>amniotic fluid embolism</subject><subject>Blood Transfusion</subject><subject>coagulopathy</subject><subject>Disseminated Intravascular Coagulation - etiology</subject><subject>Disseminated Intravascular Coagulation - physiopathology</subject><subject>Disseminated Intravascular Coagulation - therapy</subject><subject>Embolism, Amniotic Fluid - complications</subject><subject>Embolism, Amniotic Fluid - physiopathology</subject><subject>Embolism, Amniotic Fluid - therapy</subject><subject>Embolization, Therapeutic</subject><subject>Fatty Liver - complications</subject><subject>Fatty Liver - physiopathology</subject><subject>Fatty Liver - therapy</subject><subject>Female</subject><subject>Fetal Death - complications</subject><subject>Fetal Death - physiopathology</subject><subject>Fetal Death - therapy</subject><subject>fibrinolysis</subject><subject>haemostatis</subject><subject>Hemolytic-Uremic Syndrome - complications</subject><subject>Hemolytic-Uremic Syndrome - physiopathology</subject><subject>Hemolytic-Uremic Syndrome - therapy</subject><subject>Humans</subject><subject>low-grade DIC</subject><subject>massive haemorrhage</subject><subject>Placenta Accreta - complications</subject><subject>Placenta Accreta - physiopathology</subject><subject>Placenta Accreta - therapy</subject><subject>Plasma</subject><subject>Plasma Substitutes - therapeutic use</subject><subject>pre-eclampsia</subject><subject>Pre-Eclampsia - complications</subject><subject>Pre-Eclampsia - physiopathology</subject><subject>Pre-Eclampsia - therapy</subject><subject>Pregnancy</subject><subject>Pregnancy Complications, Cardiovascular - etiology</subject><subject>Pregnancy Complications, Cardiovascular - physiopathology</subject><subject>Pregnancy Complications, Cardiovascular - therapy</subject><subject>Purpura, Schoenlein-Henoch - complications</subject><subject>Purpura, Schoenlein-Henoch - physiopathology</subject><subject>Purpura, Schoenlein-Henoch - therapy</subject><subject>sepsis</subject><subject>transfusion</subject><issn>1521-6934</issn><issn>1532-1932</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kDtPwzAUhS0EoqWwMqJO3RLutZ00HlF5SpVYYLYc-6YyyqPYSSX-PYlaiYnpnuE7R7ofY7cIKUIm7kvqdikHwBQ4yDM2x0zwBJXg51PmmORKyBm7ivELQAjFs0s2Q5TrokA1Z6tHHyM1vjU9uaVv-2AOJtqhNmFpO7MbQ--79ppdVKaOdHO6C_b5_PSxeU227y9vm4dtYoWEPlGSMC8rgLUjsiTKXCjluM1MZYQwtloXzqCqCigKlztEJTlJ5JaDUlJysWCr4-4-dN8DxV43Plqqa9NSN0S9RhixbALTI2hDF2OgSu-Db0z40Qh6MqMnM3oyoyczY-HutDyUDbk__KRiBIojQON_B09BR-upteR8INtr1_n_tn8BGdxxWQ</recordid><startdate>20010801</startdate><enddate>20010801</enddate><creator>Letsky, Elizabeth A.</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20010801</creationdate><title>Disseminated intravascular coagulation</title><author>Letsky, Elizabeth A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c340t-94e16bf007deece3b6399d2c5afa33acf78da19f8088d6d11942e412c20994423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Abortion, Therapeutic - adverse effects</topic><topic>abruptio placentae</topic><topic>Abruptio Placentae - complications</topic><topic>Abruptio Placentae - physiopathology</topic><topic>Abruptio Placentae - therapy</topic><topic>amniotic fluid embolism</topic><topic>Blood Transfusion</topic><topic>coagulopathy</topic><topic>Disseminated Intravascular Coagulation - etiology</topic><topic>Disseminated Intravascular Coagulation - physiopathology</topic><topic>Disseminated Intravascular Coagulation - therapy</topic><topic>Embolism, Amniotic Fluid - complications</topic><topic>Embolism, Amniotic Fluid - physiopathology</topic><topic>Embolism, Amniotic Fluid - therapy</topic><topic>Embolization, Therapeutic</topic><topic>Fatty Liver - complications</topic><topic>Fatty Liver - physiopathology</topic><topic>Fatty Liver - therapy</topic><topic>Female</topic><topic>Fetal Death - complications</topic><topic>Fetal Death - physiopathology</topic><topic>Fetal Death - therapy</topic><topic>fibrinolysis</topic><topic>haemostatis</topic><topic>Hemolytic-Uremic Syndrome - complications</topic><topic>Hemolytic-Uremic Syndrome - physiopathology</topic><topic>Hemolytic-Uremic Syndrome - therapy</topic><topic>Humans</topic><topic>low-grade DIC</topic><topic>massive haemorrhage</topic><topic>Placenta Accreta - complications</topic><topic>Placenta Accreta - physiopathology</topic><topic>Placenta Accreta - therapy</topic><topic>Plasma</topic><topic>Plasma Substitutes - therapeutic use</topic><topic>pre-eclampsia</topic><topic>Pre-Eclampsia - complications</topic><topic>Pre-Eclampsia - physiopathology</topic><topic>Pre-Eclampsia - therapy</topic><topic>Pregnancy</topic><topic>Pregnancy Complications, Cardiovascular - etiology</topic><topic>Pregnancy Complications, Cardiovascular - physiopathology</topic><topic>Pregnancy Complications, Cardiovascular - therapy</topic><topic>Purpura, Schoenlein-Henoch - complications</topic><topic>Purpura, Schoenlein-Henoch - physiopathology</topic><topic>Purpura, Schoenlein-Henoch - therapy</topic><topic>sepsis</topic><topic>transfusion</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Letsky, Elizabeth A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Best practice &amp; research. Clinical obstetrics &amp; gynaecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Letsky, Elizabeth A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Disseminated intravascular coagulation</atitle><jtitle>Best practice &amp; research. Clinical obstetrics &amp; gynaecology</jtitle><addtitle>Best Pract Res Clin Obstet Gynaecol</addtitle><date>2001-08-01</date><risdate>2001</risdate><volume>15</volume><issue>4</issue><spage>623</spage><epage>644</epage><pages>623-644</pages><issn>1521-6934</issn><eissn>1532-1932</eissn><abstract>Healthy pregnancy is accompanied by changes in the haemostatic system which convert it into a hypercoagulable state vulnerable to a spectrum of disorders ranging from venous thromboembolism to disseminated intravascular coagulation (DIC). This latter is always a secondary phenomenon triggered by specific disorders such as abruptio placentae and amniotic fluid embolism due to release of thromboplastin intravascularly or endothelial damage resulting from pre-eclampsia and sepsis. In modern obstetric practice the most common cause is haemorrhagic shock with delay in resuscitation leading to endothelial damage. The initial management of massive obstetric haemorrhage is the same whether associated with coagulopathy initially or not. Low-grade DIC, associated with pre-eclampsia, is monitored haematologically by serial platelet counts and serum fibrin degradation products (FDPs). Supportive measures and removal of the triggering mechanism are the key to successful management. Outcome depends primarily on our ability to deal with the trigger and not on direct attempts to correct the coagulation deficit.</abstract><cop>Netherlands</cop><pub>Elsevier Ltd</pub><pmid>11478819</pmid><doi>10.1053/beog.2001.0204</doi><tpages>22</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1521-6934
ispartof Best practice & research. Clinical obstetrics & gynaecology, 2001-08, Vol.15 (4), p.623-644
issn 1521-6934
1532-1932
language eng
recordid cdi_proquest_miscellaneous_71044252
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Abortion, Therapeutic - adverse effects
abruptio placentae
Abruptio Placentae - complications
Abruptio Placentae - physiopathology
Abruptio Placentae - therapy
amniotic fluid embolism
Blood Transfusion
coagulopathy
Disseminated Intravascular Coagulation - etiology
Disseminated Intravascular Coagulation - physiopathology
Disseminated Intravascular Coagulation - therapy
Embolism, Amniotic Fluid - complications
Embolism, Amniotic Fluid - physiopathology
Embolism, Amniotic Fluid - therapy
Embolization, Therapeutic
Fatty Liver - complications
Fatty Liver - physiopathology
Fatty Liver - therapy
Female
Fetal Death - complications
Fetal Death - physiopathology
Fetal Death - therapy
fibrinolysis
haemostatis
Hemolytic-Uremic Syndrome - complications
Hemolytic-Uremic Syndrome - physiopathology
Hemolytic-Uremic Syndrome - therapy
Humans
low-grade DIC
massive haemorrhage
Placenta Accreta - complications
Placenta Accreta - physiopathology
Placenta Accreta - therapy
Plasma
Plasma Substitutes - therapeutic use
pre-eclampsia
Pre-Eclampsia - complications
Pre-Eclampsia - physiopathology
Pre-Eclampsia - therapy
Pregnancy
Pregnancy Complications, Cardiovascular - etiology
Pregnancy Complications, Cardiovascular - physiopathology
Pregnancy Complications, Cardiovascular - therapy
Purpura, Schoenlein-Henoch - complications
Purpura, Schoenlein-Henoch - physiopathology
Purpura, Schoenlein-Henoch - therapy
sepsis
transfusion
title Disseminated intravascular coagulation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T01%3A01%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Disseminated%20intravascular%20coagulation&rft.jtitle=Best%20practice%20&%20research.%20Clinical%20obstetrics%20&%20gynaecology&rft.au=Letsky,%20Elizabeth%20A.&rft.date=2001-08-01&rft.volume=15&rft.issue=4&rft.spage=623&rft.epage=644&rft.pages=623-644&rft.issn=1521-6934&rft.eissn=1532-1932&rft_id=info:doi/10.1053/beog.2001.0204&rft_dat=%3Cproquest_cross%3E71044252%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71044252&rft_id=info:pmid/11478819&rft_els_id=S1521693401902044&rfr_iscdi=true